The US Food and Drug Administration soon will consider whether to approve a new Alzheimer's drug for the first time in almost two decades.

Next
« Prev Post
« Prev Post
Previous
Next Post »
Next Post »
Subscribe to:
Post Comments (Atom)
ConversionConversion EmoticonEmoticon